Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



10X Capital Venture Acquisition Corp. III Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/06/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FORM OF NON-REDEMPTION AGREEMENT"
10/05/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "Press Release"
08/10/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: "AGREEMENT AND PLAN OF MERGER",
"ACQUIROR SUPPORT AGREEMENT This ACQUIROR SUPPORT AGREEMENT , dated as of August 9, 2023, is made by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company , American Gene Technologies International Inc., a Delaware corporation , 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company , and the undersigned directors and officers of 10X . 10X, AGT and the Class B Holders shall be referred to herein from time to time collectively as the “ Parties ” and individually as a “ Party .” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement . WHEREAS, 10X, AGT and 10X AGT Merger Sub, LLC, a Delaware limited liability company , entered into that certain Agreement and Plan of M...",
"FORM OF COMPANY SUPPORT AGREEMENT",
"FORM OF LOCK-UP AGREEMENT",
"A CLINICAL STAGE HIV-FOCUSED GENE THERAPY COMPANY, TO GO PUBLIC THROUGH BUSINESS COMBINATION WITH 10X CAPITAL VENTURE ACQUISITION CORP."
07/11/2023 8-K Quarterly results
02/03/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits...
Docs: "SETTLEMENT AGREEMENT AND MUTUAL RELEASE"
02/01/2023 8-K Quarterly results
12/28/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X III"
12/21/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
12/21/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "AGREEMENT AND PLAN OF MERGER dated as of by and among 10X CAPITAL VENTURE ACQUISITION Corp. III, 10X Sparks Merger Sub, Inc.,",
"Acquiror Support Agreement, by and among 10X Capital Venture Acquisition Corp. III, Sparks Energy, Inc., 10X Capital SPAC Sponsor III LLC and the directors and executive officers of 10X Capital Venture Acquisition Corp. III named therein",
"Company Support Agreement, by and among 10X Capital Venture Acquisition Corp. III, Ottis J. Sparks and, solely with respect to Section 1(a) thereto, Sparks Energy, Inc",
"Form of Lock-Up Agreement",
"[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]",
"SPARKS ENERGY, A LEADER IN POWER INFRASTRUCTURE SERVICES AND RESTORATION, TO LIST ON NEW YORK STOCK EXCHANGE THROUGH MERGER WITH 10X CAPITAL VENTURE ACQUISITION CORP. III"
12/09/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Form of Non-Redemption Agreement"
03/01/2022 8-K Other Events, Financial Statements and Exhibits
Docs: "10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022"
01/21/2022 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet as of January 14, 2022",
"Audited Balance Sheet as of January 14, 2022"
01/14/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : January 11, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III Cayman Islands 001-41216 98-1594494 1 World Trade Center, 85 th Floor 10007 Registrant's telephone number, including area code: 257-0069 Not Applicable Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant VCXB.U New York Stock Exchange Class A ordinary shares, par value $0.0001 par value VCXB New York Stock Exchange Warrants, each whole warrant exercisable for one...",
"Underwriting Agreement, by and between the Company and Cantor Fitzgerald & Co., as representative of the underwriters",
"Amended and Restated Memorandum and Articles of Association",
"Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent",
"Letter Agreement, by and among the Company, its executive officers, its directors and 10X Capital SPAC Sponsor III LLC",
"Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, by and among the Company, 10X Capital SPAC Sponsor III LLC and the Holders signatory thereto",
"Private Placement Units Purchase Agreement, by and between the Company and 10X Capital SPAC Sponsor III LLC",
"Private Placement Units Purchase Agreement, by and between the Company and Cantor Fitzgerald & Co",
"Administrative Services Agreement, by and between the Company and 10X Capital SPAC Sponsor III LLC",
"10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering , Jan. 11, 2022 — 10X Capital Venture Acquisition Corp. III today announced the pricing of its upsized initial public offering of 26,100,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol “VCXB.U” beginning on January 12, 2022. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE und..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy